Skip to main content
The BMJ logoLink to The BMJ
letter
. 1994 Nov 19;309(6965):1372–1373.

Serum screening for Down's syndrome. National policy would ensure consistency.

T Reynolds, R John
PMCID: PMC2541876  PMID: 7866102

Full text

PDF
1372

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fearn J., Hibbard B. M., Laurence K. M., Roberts A., Robinson J. O. Screening for neural-tube defects and maternal anxiety. Br J Obstet Gynaecol. 1982 Mar;89(3):218–221. doi: 10.1111/j.1471-0528.1982.tb03618.x. [DOI] [PubMed] [Google Scholar]
  2. Green J. M. Serum screening for Down's syndrome: experiences of obstetricians in England and Wales. BMJ. 1994 Sep 24;309(6957):769–772. doi: 10.1136/bmj.309.6957.769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Smith D. K., Shaw R. W., Marteau T. M. Informed consent to undergo serum screening for Down's syndrome: the gap between policy and practice. BMJ. 1994 Sep 24;309(6957):776–776. doi: 10.1136/bmj.309.6957.776. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES